Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study).

Ko YG, Lee BK, Kang WC, Moon JY, Cho YH, Choi SH, Hong MK, Jang Y, Kim JY, Min PK, Kwon HM; PRINCIPLE Investigators.

Yonsei Med J. 2013 Jul;54(4):957-64. doi: 10.3349/ymj.2013.54.4.957.

2.

Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.

Fan Y, Wei Q, Cai J, Shi Y, Zhang Y, Yao L, Wang X, Lin S, Li Y, Lv J, Zhou B, Du R.

Heart Vessels. 2016 Nov;31(11):1776-1782. Epub 2016 Feb 13.

PMID:
26874946
3.

Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.

Nawa T, Nishigaki K, Kinomura Y, Tanaka T, Yamada Y, Kawasaki M, Minatoguchi S.

Int J Cardiol. 2015 Sep 15;195:228-34. doi: 10.1016/j.ijcard.2015.05.078. Epub 2015 May 22.

PMID:
26048382
4.

Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.

Shin DH, Choi DJ, Youn TJ, Yoon CH, Suh JW, Kim KI, Cho YS, Cho GY, Chae IH, Kim CH.

Am J Cardiol. 2011 Jul 15;108(2):189-94. doi: 10.1016/j.amjcard.2011.03.019. Epub 2011 May 3.

PMID:
21545991
5.

Brain natriuretic peptide for prevention of contrast-induced nephropathy after percutaneous coronary intervention or coronary angiography.

Liu JM, Xie YN, Gao ZH, Zu XG, Li YJ, Hao YM, Chang L.

Can J Cardiol. 2014 Dec;30(12):1607-12. doi: 10.1016/j.cjca.2014.08.012. Epub 2014 Aug 23.

PMID:
25418218
6.

Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.

Bilasy ME, Oraby MA, Ismail HM, Maklady FA.

J Interv Cardiol. 2012 Aug;25(4):404-10. doi: 10.1111/j.1540-8183.2012.00730.x. Epub 2012 May 22.

PMID:
22612071
7.

Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.

Hernández F, Mora L, García-Tejada J, Velázquez M, Gómez-Blázquez I, Bastante T, Albarrán A, Andreu J, Tascón J.

Rev Esp Cardiol. 2009 Dec;62(12):1373-80.

8.

The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography.

Weisbord SD, Hartwig KC, Sonel AF, Fine MJ, Palevsky P.

Catheter Cardiovasc Interv. 2008 Jun 1;71(7):879-85. doi: 10.1002/ccd.21565.

PMID:
18412255
9.

Sodium bicarbonate versus isotonic saline for the prevention of contrast-induced nephropathy in patients with diabetes mellitus undergoing coronary angiography and/or intervention: a multicenter prospective randomized study.

Koc F, Ozdemir K, Altunkas F, Celik A, Dogdu O, Karayakali M, Gul EE, Erkorkmaz U, Kadi H, Akpek M, Kaya MG.

J Investig Med. 2013 Jun;61(5):872-7. doi: 10.2310/JIM.0b013e31828e9cab.

PMID:
23552179
10.

Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.

Geng W, Fu XH, Gu XS, Wang YB, Wang XC, Li W, Jiang YF, Hao GZ, Fan WZ, Xue L.

Chin Med J (Engl). 2012 Oct;125(19):3368-72.

PMID:
23044290
11.

Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.

Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, Gelormini JL, Labinaz M, Moreyra AE; Investigators of the CARE Study.

Circulation. 2007 Jun 26;115(25):3189-96. Epub 2007 Jun 11.

12.

Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.

Wang YB, Fu XH, Gu XS, Wang XC, Zhao YJ, Hao GZ, Jiang YF, Fan WZ, Wu WL, Li SQ, Xue L.

Chin Med J (Engl). 2012 Mar;125(6):1063-7.

PMID:
22613532
13.

Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.

Chen Y, Hu S, Liu Y, Zhao R, Wang L, Fu G, He Q, Su X, Zheng Y, Qi X, Liu H, Wang J, Gao W, Wang M, Liu S, Zheng X, He B, Yang P, Zhou S, Gao C, Qiu C.

EuroIntervention. 2012 Nov 22;8(7):830-8. doi: 10.4244/EIJV8I7A126.

14.

Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?

Heng AE, Cellarier E, Aublet-Cuvelier B, Decalf V, Motreff P, Marcaggi X, Deteix P, Souweine B.

Clin Nephrol. 2008 Dec;70(6):475-84.

PMID:
19049703
15.

Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.

Koc F, Ozdemir K, Kaya MG, Dogdu O, Vatankulu MA, Ayhan S, Erkorkmaz U, Sonmez O, Aygul MU, Kalay N, Kayrak M, Karabag T, Alihanoglu Y, Gunebakmaz O.

Int J Cardiol. 2012 Mar 22;155(3):418-23. doi: 10.1016/j.ijcard.2010.10.041. Epub 2010 Nov 23.

PMID:
21106264
16.
17.
18.

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.

Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.

Am Heart J. 2003 Dec;146(6):E23.

PMID:
14661012
19.

Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.

Huber W, Schipek C, Ilgmann K, Page M, Hennig M, Wacker A, Schweigart U, Lutilsky L, Valina C, Seyfarth M, Schömig A, Classen M.

Am J Cardiol. 2003 May 15;91(10):1157-62.

PMID:
12745095
20.

Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.

Juergens CP, Winter JP, Nguyen-Do P, Lo S, French JK, Hallani H, Fernandes C, Jepson N, Leung DY.

Intern Med J. 2009 Jan;39(1):25-31. doi: 10.1111/j.1445-5994.2008.01675.x. Epub 2008 Sep 2. Erratum in: Intern Med J. 2010 Apr;40(4):320.

PMID:
18771430

Supplemental Content

Support Center